Astria Therapeutics Inc. (ATXS)
NASDAQ: ATXS
· Real-Time Price · USD
6.85
0.09 (1.33%)
At close: Aug 15, 2025, 3:59 PM
6.85
0.00%
After-hours: Aug 15, 2025, 04:10 PM EDT
Astria Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -131.42M | -124.4M | -111.56M | -116.17M | -107.39M | -93.69M | -83.03M | -63.12M | -55.27M | -51.62M | -53.39M | -48.61M | -44.12M | -40.16M | -194.98M | -194.45M | -197.41M | -199.48M |
Interest Income | 14.71M | 16.46M | 17.36M | 16.2M | 14.21M | 12.12M | 10.2M | 8.42M | 6.33M | 3.99M | 1.73M | 740K | 338K | 164K | 122K | 94K | 63K | 83K |
Pretax Income | -116.92M | -108.04M | -94.26M | -100.04M | -93.24M | -81.63M | -72.89M | -54.74M | -49.01M | -47.7M | -51.83M | -48.06M | -43.94M | -40.15M | -194.91M | -194.4M | -197.39M | -199.43M |
Net Income | -116.92M | -108.04M | -94.26M | -100.04M | -93.24M | -81.63M | -72.89M | -53.72M | -47.99M | -46.67M | -50.7M | -47.95M | -43.82M | -40.04M | -194.91M | -194.4M | -197.39M | -199.43M |
Selling & General & Admin | 37.02M | 35.24M | 34.45M | 32.35M | 30.75M | 28.67M | 25.7M | 23.07M | 20.86M | 19.68M | 19.24M | 18.36M | 17.78M | 16.95M | 14.81M | 14.23M | 13.18M | 11.97M |
Research & Development | 94.4M | 89.17M | 77.11M | 68.61M | 61.44M | 49.82M | 42.13M | 40.05M | 34.41M | 31.94M | 34.26M | 30.37M | 26.46M | 23.32M | 15.55M | 15.6M | 19.62M | 22.89M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | -20K | -20K | -11K | -59K | -54K | -55K | -80K | -40K | -45K | -43K | -32K | -27K | -22K |
Operating Expenses | 131.42M | 124.4M | 111.56M | 100.97M | 92.19M | 78.49M | 67.83M | 63.12M | 55.27M | 51.62M | 53.5M | 48.72M | 44.23M | 40.27M | 30.36M | 29.84M | 32.8M | 34.87M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 131.42M | 124.4M | 111.56M | 116.17M | 107.39M | 93.69M | 83.03M | 63.12M | 55.27M | 51.62M | 53.5M | 48.72M | 44.23M | 40.27M | 30.36M | 29.84M | 32.8M | 34.87M |
Income Tax Expense | n/a | n/a | -43.28K | -43.28K | -43.28K | -43.28K | n/a | -1.03M | -1.03M | -1.03M | -1.14M | -128K | -128K | -128K | -17K | -11.5K | -22K | -88.5K |
Shares Outstanding (Basic) | 58.01M | 58.01M | 56.43M | 56.49M | 56.49M | 52.29M | 36.52M | 28.04M | 28.02M | 27.94M | 18.42M | 13.74M | 13.02M | 13.02M | 12.83M | 12.83M | 5.98M | 3.73M |
Shares Outstanding (Diluted) | 58.01M | 58.01M | 56.43M | 56.49M | 56.49M | 52.29M | 36.52M | 28.04M | 28.02M | 27.94M | 18.42M | 13.74M | 13.02M | 13.02M | 12.83M | 12.83M | 5.98M | 3.73M |
EPS (Basic) | -2.03 | -1.89 | -1.69 | -2.1 | -2.3 | -2.32 | -2.34 | -2.14 | -2.38 | -2.79 | -3.56 | -3.64 | -3.38 | -3.77 | -48.2 | -49.87 | -52.62 | -54.55 |
EPS (Diluted) | -2.03 | -1.89 | -1.69 | -2.1 | -2.3 | -2.32 | -2.34 | -2.14 | -2.38 | -2.79 | -3.56 | -3.64 | -3.38 | -3.77 | -48.2 | -49.87 | -52.62 | -54.55 |
EBITDA | -131.42M | -124.4M | -111.56M | -116.17M | -107.39M | -93.69M | -83.03M | -63.12M | -55.27M | -51.62M | -53.5M | -48.72M | -44.23M | -40.27M | -30.36M | -29.84M | -32.8M | -34.87M |
EBIT | -128.65M | -124.4M | -111.56M | -100.97M | -92.19M | -78.49M | -67.83M | -63.12M | -55.27M | -51.62M | -53.5M | -48.72M | -44.23M | -40.27M | -30.36M | -29.84M | -32.8M | -34.87M |
Depreciation & Amortization | -43.28K | -43.28K | n/a | -15.16M | -15.2M | -15.07M | -15.12M | -1.27M | -1.23M | -1.26M | -1.37M | 175.06K | 8.07M | 15.47M | 20.86M | 20.66M | 12.77M | 5.29M |